急性心肌梗死后室性心律失常应用倍他乐克联合胺碘酮治疗的效果

Effect of betaloc combined with amiodarone on ventricular arrhythmia after acute myocardial infarction

目的探究和分析急性心肌梗死后室性心律失常患者应用倍他乐克联合胺碘酮治疗的临床疗效。方法选择我院78例急性心肌梗死后室性心律失常患者作为研究对象,将其平均分成对照组和研究组,每组39例。对照组采用倍他乐克治疗,研究组采用倍他乐克联合胺碘酮治疗。比较两组患者的治疗效果。结果两组患者治疗期间的不良反应总发生率无显著差异(P>0.05);研究组患者的心室率、左心房内径大小均优于对照组(P<0.05);研究组患者治疗的总有效率明显高于对照组(P<0.05)。结论急性心肌梗死后室性心律失常患者应用倍他乐克联合胺碘酮治疗,临床疗效显著,且毒副反应少,因此其是一种安全、高效的组合治疗方案,值得临床推广。

Objective To investigate and analyze the clinical efficacy of betaloc combined with amiodarone in patients with ventricular arrhythmias after acute myocardial infarction. Methods A total of 78 patients with ventricular arrhythmia after acute myocardial infarction in our hospital were selected as the study objects. They were equally divided into control group and study group, with 39 cases in each group. The control group was treated with betaloc, and the study group was treated with betaloc combined with amiodarone. The treatment effects of the two groups were compared. Results There was no significant difference in the total incidence of adverse reactions between the two groups（P〈0.05）. The ventricular rate and the size of the left atrium in the study group were better than those in the control group（P〈0.05）. The total effective rate of the study group was significantly higher than that of the control group（P〈0.05）. Conclusion The application of betaloc combined with amiodarone in patients with ventricular arrhythmia after acute myocardial infarction has obvious clinical curative effect and less side effects. Therefore, it is a safe and effective combination regimen.